Recurrent hypoglycemia increases oxygen glucose deprivation-induced damage in hippocampal organotypic slices

Neuroscience Letters

Volumn 496, Issue 1, 2011, Pages 25-29

  Dave, Kunjan R ^a   Pileggi, Antonello ^a   Raval, Ami P ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Brain ischemia; Cardiac arrest; Diabetes; Glucose; Intensive insulin therapy; Recurrent hypoglycemia; Secondary complications; Stroke

Indexed keywords

INSULIN;

ARTICLE; BRAIN CELL; BRAIN ISCHEMIA; CELL DEATH; CONTROLLED STUDY; EX VIVO STUDY; GLUCOSE TOLERANCE; HUMAN; HUMAN CELL; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INTENSIVE CARE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; STROKE;

ANIMALS; ANIMALS, NEWBORN; ANOXIA; CELL DEATH; EXCITATORY AMINO ACID AGONISTS; GLUCOSE; HIPPOCAMPUS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; N-METHYLASPARTATE; NEURONS; ORGAN CULTURE TECHNIQUES; OXYGEN; RATS; TIME FACTORS;

EID: 79955641157     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.03.079     Document Type: Article

References (38)

1. Alquier T., Kawashima J., Tsuji Y., Kahn B.B. Role of hypothalamic adenosine 5′-monophosphate-activated protein kinase in the impaired counterregulatory response induced by repetitive neuroglucopenia. Endocrinology 2007, 148:1367-1375.
2. Boland E., Monsod T., Delucia M., Brandt C.A., Fernando S., Tamborlane W.V. Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. Diab. Care 2001, 24:1858-1862.
3. Bolli G., de Feo P., Compagnucci P., Cartechini M.G., Angeletti G., Santeusanio F., Brunetti P., Gerich J.E. Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion. Diabetes 1983, 32:134-141.
4. Cryer P.E. Diverse causes of hypoglycemia-associated autonomic failure in diabetes. N. Engl. J. Med. 2004, 350:2272-2279.
5. Cryer P.E. Hypoglycemia in diabetes: pathophysiological mechanisms and diurnal variation. Prog. Brain Res. 2006, 153:361-365.
6. Dagogo-Jack S.E., Craft S., Cryer P.E. Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia. J. Clin. Invest. 1993, 91:819-828.
7. Dave K.R., Tamariz J., Desai K.M., Brand F.J., Liu A., Saul I., Bhattacharya S.K., Pileggi A Recurrent hypoglycemia exacerbates cerebral ischemic damage in streptozotocin-induced diabetic rats. Stroke 2011, 42:1404-1411.
8. DCCT Hypoglycemia in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group. Diabetes 1997, 46:271-286.
9. DCCT Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 2003, 290:2159-2167.
10. DCCTRG The effect of intensive diabetes therapy on the development and progression of neuropathy. The Diabetes Control and Complications Trial Research Group. Ann. Intern. Med. 1995, 122:561-568.
11. del Zoppo G.J. The neurovascular unit in the setting of stroke. J. Intern. Med. 2010, 267:156-171.
12. Dirnagl U., Simon R.P., Hallenbeck J.M. Ischemic tolerance and endogenous neuroprotection. Trends Neurosci. 2003, 26:248-254.
13. Fioramonti X., Marsollier N., Song Z., Fakira K.A., Patel R.M., Brown S., Duparc T., Pica-Mendez A., Sanders N.M., Knauf C., Valet P., McCrimmon R.J., Beuve A., Magnan C., Routh V.H. Ventromedial hypothalamic nitric oxide production is necessary for hypoglycemia detection and counterregulation. Diabetes 2010, 59:519-528.
14. Gidday J.M. Cerebral preconditioning and ischaemic tolerance. Nat. Rev. Neurosci. 2006, 7:437-448.
15. Group T.D.C.a.C.T.R. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N. Engl. J. Med. 1993, 329:977-986.
16. (accessed 03.09.10). http://www.diabetes.org/living-with-diabetes/complications/stroke.html.
17. Inouye K., Shum K., Chan O., Mathoo J., Matthews S.G., Vranic M. Effects of recurrent hyperinsulinemia with and without hypoglycemia on counterregulation in diabetic rats. Am. J. Physiol. Endocrinol. Metab. 2002, 282:E1369-E1379.
18. Kauppinen R.A., Nicholls D.G. Synaptosomal bioenergetics. The role of glycolysis, pyruvate oxidation and responses to hypoglycaemia. Eur. J. Biochem. 1986, 158:159-165.
19. Kim E., Raval A.P., Defazio R.A., Perez-Pinzon M.A. Ischemic preconditioning via epsilon protein kinase C activation requires cyclooxygenase-2 activation in vitro. Neuroscience 2007, 145:931-941.
20. Kim R., Emi M., Tanabe K., Murakami S., Uchida Y., Arihiro K. Regulation and interplay of apoptotic and non-apoptotic cell death. J. Pathol. 2006, 208:319-326.
21. Larsen G.A., Skjellegrind H.K., Berg-Johnsen J., Moe M.C., Vinje M.L. Depolarization of mitochondria in isolated CA1 neurons during hypoxia, glucose deprivation and glutamate excitotoxicity. Brain Res. 2006, 1077:153-160.
22. Leese G.P., Wang J., Broomhall J., Kelly P., Marsden A., Morrison W., Frier B.M., Morris A.D. Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: a population-based study of health service resource use. Diab. Care 2003, 26:1176-1180.
23. Li Z.G., Britton M., Sima A.A., Dunbar J.C. Diabetes enhances apoptosis induced by cerebral ischemia. Life Sci. 2004, 76:249-262.
24. Lingenfelser T., Renn W., Sommerwerck U., Jung M.F., Buettner U.W., Zaiser-Kaschel H., Kaschel R., Eggstein M., Jakober B. Compromised hormonal counterregulation, symptom awareness, and neurophysiological function after recurrent short-term episodes of insulin-induced hypoglycemia in IDDM patients. Diabetes 1993, 42:610-618.
25. Lipton P. Ischemic cell death in brain neurons. Physiol. Rev. 1999, 79:1431-1568.
26. Mallard E.C., Williams C.E., Gunn A.J., Gunning M.I., Gluckman P.D. Frequent episodes of brief ischemia sensitize the fetal sheep brain to neuronal loss and induce striatal injury. Pediatr. Res. 1993, 33:61-65.
27. McCrimmon R. The mechanisms that underlie glucose sensing during hypoglycaemia in diabetes. Diab. Med. 2008, 25:513-522.
28. McCrimmon R.J., Fan X., Cheng H., McNay E., Chan O., Shaw M., Ding Y., Zhu W., Sherwin R.S. Activation of AMP-activated protein kinase within the ventromedial hypothalamus amplifies counterregulatory hormone responses in rats with defective counterregulation. Diabetes 2006, 55:1755-1760.
29. McGowan J.E., Chen L., Gao D., Trush M., Wei C. Increased mitochondrial reactive oxygen species production in newborn brain during hypoglycemia. Neurosci. Lett. 2006, 399:111-114.
30. Puente E.C., Silverstein J., Bree A.J., Musikantow D.R., Wozniak D.F., Maloney S., Daphna-Iken D., Fisher S.J. Recurrent moderate hypoglycemia ameliorates brain damage and cognitive dysfunction induced by severe hypoglycemia. Diabetes 2010, 59:1055-1062.
31. Raval A.P., Dave K.R., Mochly-Rosen D., Sick T.J., Perez-Pinzon M.A. Epsilon PKC is required for the induction of tolerance by ischemic and NMDA-mediated preconditioning in the organotypic hippocampal slice. J. Neurosci. 2003, 23:384-391.
32. Sakurai T., Yang B., Takata T., Yokono K. Synaptic adaptation to repeated hypoglycemia depends on the utilization of monocarboxylates in Guinea pig hippocampal slices. Diabetes 2002, 51:430-438.
33. Silver I.A., Erecinska M. Extracellular glucose concentration in mammalian brain: continuous monitoring of changes during increased neuronal activity and upon limitation in oxygen supply in normo-, hypo-, and hyperglycemic animals. J. Neurosci. 1994, 14:5068-5076.
34. S. Suh, B. Yoo, J. Liu, S. Won, Recurrent mild hypoglycemia induces synaptic injury in the hippocampus Society for Neuroscience Conference, Poster#: 440. 3 (2009).
35. Suh S.W., Gum E.T., Hamby A.M., Chan P.H., Swanson R.A. Hypoglycemic neuronal death is triggered by glucose reperfusion and activation of neuronal NADPH oxidase. J. Clin. Invest. 2007, 117:910-918.
36. Tamborlane W.V., Beck R.W., Bode B.W., Buckingham B., Chase H.P., Clemons R., Fiallo-Scharer R., Fox L.A., Gilliam L.K., Hirsch I.B., Huang E.S., Kollman C., Kowalski A.J., Laffel L., Lawrence J.M., Lee J., Mauras N., O'Grady M., Ruedy K.J., Tansey M., Tsalikian E., Weinzimer S., Wilson D.M., Wolpert H., Wysocki T., Xing D. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N. Engl. J. Med. 2008, 359:1464-1476.
37. Tanaka Y., Takata T., Satomi T., Sakurai T., Yokono K. The double-edged effect of insulin on the neuronal cell death associated with hypoglycemia on the hippocampal slice culture. Kobe J. Med. Sci. 2008, 54:E97-107.
38. Xu G.P., Dave K.R., Vivero R., Schmidt-Kastner R., Sick T.J., Perez-Pinzon M.A. Improvement in neuronal survival after ischemic preconditioning in hippocampal slice cultures. Brain Res. 2002, 952:153-158.